Graduation Year

2024

Document Type

Dissertation

Degree

Ph.D.

Degree Name

Doctor of Philosophy (Ph.D.)

Degree Granting Department

Molecular Biosciences

Major Professor

Shari Pilon-Thomas, Ph.D.

Committee Member

Daniel Abate-Daga, Ph.D.

Committee Member

Katarzyna Rejniak, Ph.D.

Committee Member

George Blanck, Ph.D.

Keywords

T cell, acidosis, MDSC, immunosuppression, recurrence

Abstract

Bladder cancer is the tenth most common cancer in the world and has one of the highest recurrence rates. Despite the local delivery options and mutational status of bladder tumors, responses with immunotherapies have been limited with low durability. The bladder tumor microenvironment is enriched with highly immunosuppressive populations and harsh conditions that restrict anti-tumor immunity and subsequently attenuate immunotherapy response. We predict that targeting two of these immunosuppressive components, namely acidity and myeloid derived suppressor cells (MDSCs), will bolster T cell responses and enhance outcomes with immunotherapy. In Chapter 2, we characterized the effects of acidity on T cell function and connected this to activation of TGF-β signaling. We explored neutralization of tumor acidity in vivo using sodium bicarbonate water and found enhancements to T cell immunity and anti-tumor responses. In Chapter 3, we characterized MDSCs and their immunosuppressive effects in bladder cancer patient samples and murine models of bladder cancer. We depleted MDSCs using local delivery of low-dose gemcitabine and induced enhanced anti-tumor responses in combination with local delivery of OT-I T cells. Altogether, we show that targeting acidity and MDSCs in the bladder tumor microenvironment are effective strategies to reinforce T cells responses. We predict that combining these treatment strategies with immunotherapy will reduce recurrences in bladder cancer and increase durability of treatment response.

Share

COinS